DiRienzo Joseph M, Cao Linsen, Volgina Alla, Bandelac Georges, Korostoff Jonathan
Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104-6030, USA.
FEMS Microbiol Lett. 2009 Feb;291(2):222-31. doi: 10.1111/j.1574-6968.2008.01457.x. Epub 2008 Dec 11.
Chimeras composed of the cdtB gene of a novel bacterial genotoxin and the human type I DNAse I gene were constructed and their products characterized relative to the biochemical and enzymatic properties of the native proteins. The product of a cdtB/DNAse I chimera formed a heterotrimer with the CdtA and CdtC subunits of the genotoxin, and targeted mutations increased the specific activity of the hybrid protein. Expression of active chimeric gene products established that the CdtB protein is an atypical divalent cation-dependent endonuclease and demonstrated the potential for genetically engineering a new class of therapeutic agent for inhibiting the proliferation of cancer cells.
构建了由新型细菌基因毒素的cdtB基因与人类I型脱氧核糖核酸酶I基因组成的嵌合体,并根据天然蛋白质的生化和酶学特性对其产物进行了表征。cdtB/脱氧核糖核酸酶I嵌合体的产物与基因毒素的CdtA和CdtC亚基形成异源三聚体,靶向突变提高了杂合蛋白的比活性。活性嵌合基因产物的表达证实CdtB蛋白是一种非典型的二价阳离子依赖性内切核酸酶,并证明了通过基因工程制造一类新型治疗剂以抑制癌细胞增殖具有可能性。